Hennepin Healthcare
Department of Laboratory Medicine and Pathology
701 Park Ave. S
Minneapolis, MN 55415
ComACC Accredited: 2013
| Program Director | Program Admin |
|---|---|
| Fred Apple, PhD, DABCC | Stephanie Leiviska |
| Professor of Laboratory Medicine and Pathology; Medical Director, Forensic Toxicology | Program Coordinator |
| Please address communications to Dr. Hannah Brown hannah.brown@hcmed.org | Stephanie.Leiviska@hcmed.org |
| (612) 873-9005 | (612) 873-2983 |
About the Program
The fellowship program in clinical chemistry and toxicology combines training in the analytical, clinical, regulatory and administrative aspects of clinical chemistry, toxicology and molecular diagnostics with applied research experience. The training is designed to prepare the candidate for a career in academic laboratory medicine, clinical practice, industry, or private reference laboratory practices by providing a foundation to apply to future developments in clinical pathology as well as current practice. The training program is organized in the Department of Laboratory Medicine and Pathology within the Hennepin Healthcare system. Extensive training in clinical and forensic toxicology in conjunction with the Minnesota Poison Control Center and Medical Examiner’s office is included. The primary training faculty includes 6 individuals of varied backgrounds and interests. The period of the fellowship is two years.
Program Requirements
To be considered for the program, prospective fellows must have:
- PhD in physical or biological sciences or an MD degree from an appropriately accredited university or college.
- Minimum of 30 semester hours (undergraduate or graduate level) of coursework in chemistry or biochemistry prior to admission into the training program is required.
Trainee selection will conform to institutional requirements for equal employment opportunity and be based solely on qualifications related to successful completion of the training program.
To Apply
Applications accepted September through April of year preceding the July start date. Currently accepting applications for a July 2026 start date. Start dates will be July 1 (preferred), November 1, or March 1 so that recruiting is not confined to one time of year.
The application packet must include:
- Letter of interest
- Curriculum vitae
- Three letters of recommendation
Selected applicants may be invited to an in-person interview which includes a seminar presentation.
Training Level
| Postdoctoral Training Level |
|---|
| Number of positions available per year: 1 every other year (currently accepting for July 2026) |
| Duration of program: 2 years |
| Approximate annual salary or stipend: PGY Scale |
| Source of funding: Educational Grants, Department Funding |
| Current number of trainees: 0 |
| Number of past graduates: 7 |
Faculty
| Fred S. Apple, PhD, DABCC | Cardiovascular Biomarkers, Pharmacogenomics, Forensic Toxicology, Mass Spectrometry |
| Sarah Drawz, MD, PhD | Hematopathology, Cytogenetics |
| James Fink, MD, PhD | Cytogenetics, Genotyping |
| Melissa Lallak, MT, MBA | Administration, Regulatory Operations |
| Margret Oethinger, MD, PhD, D(ABMM) | Microbiology, Molecular Diagnostics |
| Hannah Brown, PhD | Clinical Chemistry, Clinical & Forensic Toxicology, Mass Spectrometry, Informatics, Cardiac Biomarkers, Diabetes, Point-of-Care Testing, Laboratory Quality Assurance/Operations |